Literature DB >> 12831815

Visceral obesity is characterized by impaired nitric oxide-independent vasodilation.

S Vigili de Kreutzenberg1, E Kiwanuka, A Tiengo, A Avogaro.   

Abstract

BACKGROUND: Endothelial dysfunction has been described in obesity. This study examines the impact of visceral obesity on nitric oxide-independent relaxation in the human forearm. METHODS AND
RESULTS: In ten viscerally obese and ten matched controls forearm blood flow (FBF) was measured by venous occlusion plethysmography during intrabrachial infusion of: (1) sodium nitroprusside; (2) bradykinin, before and after inhibition of vasoactive prostaglandins and nitric oxide; (3) potassium; (4) ouabain (Na(+)/K(+)ATPase inhibitor) alone or (5) in combination with BaCl(2)(K(IR)inhibitor). Baseline FBF and endothelium-independent vasodilatation were similar in the two groups. In obese patients, bradykinin-induced increase of FBF was significantly less than in controls (P<0.01). Irrespective of prostaglandins and nitric oxide inhibition, bradykinin response was lower in the viscerally obese. Intrabrachial potassium determined a significantly blunted response (P<0.05). Ouabain caused a similar, moderate decrease in basal FBF in the two groups; the coinfusion of BaCl(2)caused a more intense decline in FBF which was significantly relevant in obese (-24+/-5%, P<0.01).
CONCLUSIONS: In obese patients there is a blunted nitric oxide-independent relaxation determined by a decreased response of inwardly rectifying potassium channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831815     DOI: 10.1016/s0195-668x(03)00206-9

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

Review 1.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

Authors:  A Enrique Caballero
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

2.  Reduced flow-and acetylcholine-induced dilations in visceral compared to subcutaneous adipose arterioles in human morbid obesity.

Authors:  Ivana Grizelj; Ana Cavka; Jing-Tan Bian; Mary Szczurek; Austin Robinson; Shruti Shinde; Van Nguyen; Carol Braunschweig; Edward Wang; Ines Drenjancevic; Shane A Phillips
Journal:  Microcirculation       Date:  2015-01       Impact factor: 2.628

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

5.  PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid.

Authors:  Shailendra P Singh; Joseph Schragenheim; Jian Cao; John R Falck; Nader G Abraham; Lars Bellner
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-07-11       Impact factor: 3.072

6.  Associations of sex, age and adiposity in endothelium-independent dilation in children.

Authors:  Michelle M Harbin; Hanan Zavala; Justin R Ryder; Julia Steinberger; Alan R Sinaiko; David R Jacobs; Donald R Dengel
Journal:  Physiol Meas       Date:  2018-04-20       Impact factor: 2.833

Review 7.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 8.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

9.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

10.  CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.

Authors:  Nader G Abraham; Komal Sodhi; Anne M Silvis; Luca Vanella; Gaia Favero; Rita Rezzani; Craig Lee; Darryl C Zeldin; Michal L Schwartzman
Journal:  Hypertension       Date:  2014-09-22       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.